G6PD and colorectal carcinoma: DHEA has also been demonstrated to act as a non-competitive glucose-6-phosphate Dehydrogenase (G6PD) enzymatic inhibitor (Marks and Banks, 1960) or an inhibitor of cholesterol and isoprenoid synthesis through endogenous mevalonate deletion in CRC (Schulz and Nyce, 1991).